Alfred Lonser, MD
Anesthesiology · Anchorage, AKNPI 1245240308
Payments from drug & device makers
Across 431 payments — averaging $36.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Nevro Corp.$2K
- AbbVie$1K
- Abbott$1K
- MML US, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$361
- plus $3K from 28 others
What the payments were for
- Travel & lodging$2,32815%
- Food & beverage$13,31785%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 165 | $6,862 |
| Nevro Corp. | 51 | $2,327 |
| AbbVie(2 entities) | 44 | $1,084 |
| Abbott | 40 | $1,066 |
| MML US, Inc. | 8 | $1,058 |
| Teva Pharmaceuticals USA, Inc. | 14 | $361 |
| Collegium Pharmaceutical, Inc. | 15 | $296 |
| Globus Medical | 2 | $272 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $228 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $228 |
| Pfizer | 13 | $228 |
| Amgen | 7 | $213 |
| GRT US Holding, Inc. | 4 | $189 |
| Merz Pharmaceuticals, LLC | 5 | $158 |
| Si-bone, Inc. | 4 | $157 |
| Boston Scientific | 2 | $137 |
| Biohaven Pharmaceuticals, Inc. | 6 | $111 |
| Averitas Pharma Inc. | 4 | $98 |
| Vertos Medical, Inc. | 1 | $70 |
| IBSA Pharma Inc. | 3 | $57 |
| Lundbeck LLC | 3 | $55 |
| Pacira Therapeutics, Inc. | 3 | $47 |
| Supernus Pharmaceuticals, Inc. | 2 | $43 |
| Azurity Pharmaceuticals, Inc. | 2 | $41 |
| Vertex | 1 | $40 |
| Alnylam Pharmaceuticals Inc. | 2 | $40 |
| Piramal Critical Care | 2 | $30 |
| Lilly USA, LLC | 1 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Tactile Systems Technology Inc | 1 | $23 |
| Indivior Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $21 |
| Bioventus LLC | 1 | $18 |
| Baudax Bio Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$1,788
- Senza$934
- INTELLIS ADAPTIVESTIM$912
- ReActiv8$874
- Accurian$480
- Omnia$471
- UBRELVY$150
- Proclaim IPG$142
- Vyrsa V1$134
- INCEPTIV$130
- KYPHON EXPRESS II KYPHOPAK TRAY$129
- AJOVY$122
- PROCLAIM$122
- NURTEC ODT$122
- iFuse Implant$106
How this compares
$15,645 in reported general payments places this provider in the 95th percentile of 101 anesthesiology providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 43 | $28,456 |
| LinzessLinaclotide | 19 | $12,662 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 263 | $8,377 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 269 | $7,679 |
| Buprenorphine | 19 | $5,333 |
| Oxycodone Hcl | 213 | $4,068 |
| Lidocaine | 46 | $3,923 |
| Gabapentin | 190 | $2,638 |
| Morphine Sulfate ErMorphine Sulfate | 115 | $2,463 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 13 | $2,105 |
| Tizanidine Hcl | 104 | $1,114 |
| Diclofenac Sodium | 39 | $1,068 |
| Morphine Sulfate | 35 | $950 |
| Pregabalin | 79 | $816 |
| Cyclobenzaprine Hcl | 111 | $742 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $1,084 | $12,66219 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 101 anesthesiology providers in Alaska.
Other anesthesiology in Anchorage
- Shamsideen MusaAnchorage$36K
- Heath McAnallyAnchorage$1K
- Jann UrbanAnchorage$748
- Minhe KimAnchorage$424
- Anne WanaseljaAnchorage$283
- Sundrayah StollerAnchorage$281
- Pamela ToddAnchorage$222
- Mary LanzaAnchorage$207
- Colby ParksAnchorage$180
- Mark RainosekAnchorage$179
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.